Continuous cerebroventricular administration of dopamine: A new treatment for severe dyskinesia in Parkinson’s disease?

Laloux, C, Gouel, F, Lachaud, C et al. (11 more authors) (2017) Continuous cerebroventricular administration of dopamine: A new treatment for severe dyskinesia in Parkinson’s disease? Neurobiology of Disease, 103. pp. 24-31. ISSN 0969-9961

Abstract

Metadata

Authors/Creators:
Copyright, Publisher and Additional Information: © 2017 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Keywords: Parkinson's disease; Dopamine; l-dopa related motor complications; Treatment–disease modifying effect
Dates:
  • Published: July 2017
  • Accepted: 26 March 2017
  • Published (online): 29 March 2017
Institution: The University of Leeds
Academic Units: The University of Leeds > Faculty of Biological Sciences (Leeds) > School of Biomedical Sciences (Leeds)
Depositing User: Symplectic Publications
Date Deposited: 30 Mar 2017 14:15
Last Modified: 07 Oct 2017 01:29
Published Version: https://doi.org/10.1016/j.nbd.2017.03.013
Status: Published
Publisher: Elsevier
Identification Number: https://doi.org/10.1016/j.nbd.2017.03.013

Share / Export

Statistics